If Content is King, Then Conversation is Queen

The Social Media Guide

Subscribe to The Social Media Guide: eMailAlertsEmail Alerts newslettersWeekly Newsletters
Get The Social Media Guide: homepageHomepage mobileMobile rssRSS facebookFacebook twitterTwitter linkedinLinkedIn


It's All About Engaging Authors: Jim Kaskade, PR.com Newswire

Related Topics: The Social Media Guide

News Feed Item

Research Reports on Top Traded Stocks: Genworth Financial, Suntech Power Holdings, Human Genome Sciences, Sirius, Amarin and Hercules Offshore

VANCOUVER, British Columbia, Jan. 20, 2012 /PRNewswire-Asia/ -- Pennystocksinsiders.com (PSI) has issued insider trading reports and Equity Research for the following companies: Genworth Financial (NYSE:GNW), Suntech Power Holdings (NYSE:STP), Human Genome Sciences (NASDAQ:HGSI), Sirius (NASDAQ:SIRI), Amarin (NASDAQ:AMRN) and Hercules Offshore (NASDAQ:HERO).

(Logo: http://photos.prnewswire.com/prnh/20111214/HK22486LOGO )

(Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)

Report Highlights:

Genworth Financial, Inc. (NYSE:GNW): Genworth Financial, Inc. (NYSE:GNW) recently announced that it has decided to sell its tax and accounting financial advisor unit, Genworth Financial Investment Services (GFIS), to Cetera Financial Group. Genworth Financial share prices up US$0.35 to US$8.17 in the last trading session. Investors can reduce investment risk by checking insider trades in GNW. See if CEOs, CFOs, and Directors in GNW are trading the stock now.

Read Full Report: http://www.Pennystocksinsiders.com/PR/012012B/GNW/GenworthFinancial.pdf

Suntech Power Holdings Co., Ltd. (ADR) (NYSE:STP): Abnormal trading volume of Suntech Power was found yesterday which reached 13.57 million shares, nearly 5 times heavier than usual day trading. Why? Are insiders starting to take huge profits by selling shares or exercising stock options? Add STP into your watch list for insider trade now.

Read Full Report: http://www.Pennystocksinsiders.com/PR/012012B/STP/SuntechPower.pdf

Human Genome Sciences (NASDAQ:HGSI): Human Genome Sciences (NASDAQ:HGSI) stock prices reached US$9.05 for 1.46% up, 8.22 million stock shares traded as compared to its average daily volume of 6.39 million shares. Pennystocksinsiders.com thinks that it is a clever way to check if insiders like CEOs, CFOs, and Directors in HGSI are starting to buy more company shares. See insider trade report for HGSI here. Read Full Report: http://www.Pennystocksinsiders.com/PR/012012B/HGSI/HumanGenome.pdf

Today Pennystocksinsiders.com also observed abnormal trade volume for the following companies; insiders may involve trading in these companies. It will take some time for insiders to report their trades. Read these reports and add these companies into your Insider Trade Radar.

Sirius XM Radio Inc. (NASDAQ:SIRI):
Read Full Report: http://www.Pennystocksinsiders.com/PR/012012B/SIRI/Sirius.pdf

Amarin Corporation plc (ADR) (NASDAQ:AMRN):
Read Full Report: http://www.Pennystocksinsiders.com/PR/012012B/AMRN/Amarin.pdf

Hercules Offshore, Inc. (NASDAQ:HERO):
Read Full Report: http://www.Pennystocksinsiders.com/PR/012012B/HERO/HerculesOffshore.pdf

More Individual Stock Reports & Sector Reports:
http://www.Pennystocksinsiders.com/mediaroom/

Insider Filing Source Reference: All observations, analysis and reports are based on public information released by the U.S. Securities and Exchange Commission.

About Pennystocksinsiders.com:

Pennystocksinsiders.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.

Important Disclaimer:
Please visit http://www.Pennystocksinsiders.com/disclaimers/index.php for details.

SOURCE Pennystocksinsiders.com

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.